AZN icon

AstraZeneca

207.48 USD
+2.54
1.24%
At close Updated Feb 24, 12:12 PM EST
1 day
1.24%
5 days
-2.44%
1 month
120.18%
3 months
126.7%
6 months
160.46%
Year to date
126.58%
1 year
177.79%
5 years
314.13%
10 years
611.77%
 

About: A merger between Astra of Sweden and Zeneca of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (over 40% of total revenue), cardiovascular, renal, and metabolic (over 20%), rare disease (16%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one-third of its sales.

Employees: 94,300

0
Funds holding %
of 7,965 funds
Analysts bullish %
0
Positive news %
Price charts implemented using Lightweight Charts™